SearchDictionaryMobileLogin

Yi-Xin Zeng Selected Research

Carcinoma (Carcinomatosis)

11/2008ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts.
05/2008Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology.
02/2008Mitochondrial DNA somatic mutations are frequent in nasopharyngeal carcinoma.
01/2008Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
01/2007Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population.
01/2007Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy.
10/2006Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk.
05/2006Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.
04/2006Adenovirus-mediated intra-tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinoma.
10/2005[Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma]
08/2005[Correlation of polymeric immunoglobulin receptor gene polymorphisms to susceptibility of nasopharyngeal carcinoma]
06/2005Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome.
01/2005Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
12/2004High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages.
11/2004Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
07/2004V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
06/2004[Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue]
03/2004Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
06/2003[Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy]
05/2002Variable sensitivity of endothelial cells to epirubicin in xenografts of human nasopharyngeal carcinoma CNE-2 cells.
02/2002The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China.

Articles by Research Topic

Disease

21Carcinoma (Carcinomatosis)
11/2008 - 02/2002
8Neoplasms (Cancer)
11/2008 - 11/2004
2Neoplasm Metastasis (Metastasis)
09/2008 - 06/2003
2Breast Neoplasms (Breast Cancer)
01/2006 - 11/2004
2Hepatocellular Carcinoma (Hepatoma)
09/2005 - 06/2004
2Leukemia
01/2004 - 02/2002
1Colonic Neoplasms (Colon Cancer)
04/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2007
1Lymphoma (Lymphomas)
02/2006
1Liver Neoplasms (Liver Cancer)
07/2004
1Hyperplasia
06/2004

Drug/Important Bio-Agent (IBA)

3AntigensIBA
05/2008 - 03/2004
3Mitochondrial DNA (mtDNA)IBA
02/2008 - 06/2004
3DNA (Deoxyribonucleic Acid)IBA
11/2004 - 06/2003
2aurora kinase (aurora A kinase)IBA
05/2008 - 03/2008
2EndostatinsIBA
04/2006 - 07/2004
1Proteins (Proteins, Gene)IBA
11/2008
1squamous cell carcinoma-related antigenIBA
09/2008
14- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA
05/2008
1AntibodiesIBA
05/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2008
1adenovirus receptorIBA
04/2008
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2008
1VX680IBA
03/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008
1Methylene Blue (Methylthioninium Chloride)FDA Link
07/2007
1steroid receptor coactivator AIB1IBA
01/2007
1Carrier Proteins (Binding Protein)IBA
01/2007
1Toll-Like Receptor 4IBA
10/2006
1Toll-Like Receptor 10IBA
05/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
02/2006
1Small Interfering RNA (siRNA)IBA
02/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2006
1N-(4-ethoyphenol)-2-hydroxy- acid amideIBA
01/2006
1involucrinIBA
10/2005
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2005
1Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
08/2005
1CXCR4 Receptors (CXCR4 Receptor)IBA
06/2005
1ClusterinIBA
01/2005
1ProteomeIBA
11/2004
1Biological Markers (Surrogate Marker)IBA
11/2004
1EnzymesIBA
06/2004
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2004
1Immunoglobulin A (IgA)IBA
03/2004
11-Phosphatidylinositol 3-Kinase (PI 3 Kinase)IBA
01/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2004
1Epirubicin (Ellence)FDA LinkGeneric
05/2002
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2002
1Caspase 3 (Caspase-3)IBA
02/2002
1squamocinIBA
02/2002

Therapy/Procedure

2Heterologous Transplantation (Xenotransplantation)
11/2008 - 05/2002
1Immunotherapy
01/2007